EUDA Health Holdings Limited
NASDAQ:EUDAMedical - Care Facilities
+$2.20 today
- Market cap
- $53.00M
- Beta
- 0.59
- P/E (TTM)
- -7.9
- EPS (TTM)
- -$1.79
Volume 0.04M
Average 0.02M
EUDA Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
EUDA Health Holdings LimitedNASDAQ: EUDA
Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026
Selling, general & admin grows, but more slowly than its trailing trend
Q2 FY2026 selling, general & admin of $1.02M rose 3.8% year over year, behind the +181.0% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -7.0% a year.
Context
- Selling, general & admin amounted to 79.7% of revenue in FY2025, down 3.7 pp from a year earlier.
- Selling, general & admin increased in 1 of the last 3 fiscal years.
What to watch
Whether selling, general & admin reaches the consensus estimate from 1 analysts of $27.86M (+412.9%) for the fiscal year ending Dec 2026, a step up from the +62.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.02M+0.0% QoQ
- Last fiscal yearDec 2025
- $5.43M+62.6% YoY
- LTMJun 2026
- $9.21M+181.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.8% | +130.2% | +126.4 pp |
| 1 year | +62.6% | +412.9% | +350.3 pp |
| 3-year CAGR | -7.0% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 5.43M USD
- Year-over-year change
- +62.6%
- 4-year CAGR
- +31.6%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.43M | +62.6% |
| FY2024 | 2024-12-31 | 3.34M | -30.4% |
| FY2023 | 2023-12-31 | 4.8M | -28.8% |
| FY2022 | 2022-12-31 | 6.75M | +273.0% |
| FY2021 | 2021-12-31 | 1.81M | — |
Selling, General & Admin vs competitors
How EUDA compares with its peers on the latest reported figures
- Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +181.0% is the highest of 7, against a peer median of -8.1%.
- Selling, general & admin amounts to 75.7% of revenue for EUDA, versus a peer median of 119.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $120.99M USD | -30.8% | -16.8% | 51.0% | |
| LTM Mar 2026 | $30.49M USD | -13.9% | -7.9% | 67.6% | |
| LTM Mar 2026 | $26.33M USD | -2.2% | -17.3% | 171.8% | |
| LTM Mar 2026 | $21.42M USD | +168.1% | — | 20.3% | |
| LTM Mar 2026 | $17.76M USD | +24.8% | +12.7% | 9346.3% | |
| LTM Mar 2026 | $17.25M USD | — | +15.2% | — | |
| LTM Jun 2026 | $9.21M USD | +181.0% | -7.0% | 75.7% | |
| LTM Mar 2026 | CA$5.32M CAD | -33.6% | -36.1% | 3202.5% | |
| Peer median (excluding EUDA) | — | -8.1% | -12.4% | 119.7% | |
Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.56M | 3.76M | 3.71M | 4.01M | 6.82M |
| Cost of Revenue | 3.31M | 2.89M | 2.86M | 3.25M | 3.83M |
| Gross Profit | 1.25M | 870K | 842.08K | 762.16K | 2.99M |
| Gross Margin | 27.4% | 23.1% | 22.7% | 19.0% | 43.9% |
| Research & Development | 129.27K | 17.21K | 0 | 0 | 249 |
| Selling, General & Admin | 1.81M | 6.75M | 4.8M | 3.34M | 5.43M |
| Operating Expenses | 1.81M | 13.09M | 4.8M | 18.1M | 5.43M |
| Depreciation & Amortization | 264.1K | 172.02K | 119.35K | 173.22K | 406.48K |
| EBITDA | 1.34M | (24.64M) | (8.29M) | (17.42M) | (2.09M) |
| EBITDA Margin | 29.4% | -654.6% | -223.7% | -434.4% | -30.7% |
| Operating Income | (559.99K) | (5.72M) | (3.96M) | (17.34M) | (2.44M) |
| Operating Margin | -12.3% | -151.9% | -106.9% | -432.2% | -35.8% |
| Interest Income | 1.92M | 0 | 0 | 0 | 0 |
| Interest Expense | 127.13K | 93.78K | 23.23K | 44.89K | 228.62K |
| Other Income / Expenses | 2.23M | (19.21M) | (4.47M) | (307.38K) | (285.26K) |
| Income Before Tax | 1.67M | (24.93M) | (8.43M) | (17.64M) | (2.73M) |
| Pre-Tax Margin | 36.6% | -662.3% | -227.6% | -439.8% | -40.0% |
| Income Tax Expense | 46.49K | (20.79K) | 0 | (4.38K) | 41.94K |
| Net Income | 864.83K | (24.88M) | (10.04M) | (15.36M) | (2.77M) |
| Net Margin | 19.0% | -661.1% | -270.9% | -382.9% | -40.7% |
| EPS (Basic) | 1.87 | (41.40) | (8.80) | (9.40) | (1.49) |
| EPS (Diluted) | 1.87 | (41.40) | (8.80) | (9.40) | (1.49) |
| Weighted Avg Shares | 462.67K | 601.48K | 1.15M | 1.62M | 1.86M |
| Weighted Avg Shares (Diluted) | 462.67K | 601.48K | 1.15M | 1.62M | 1.86M |
EUDA Health Holdings Limited
NASDAQ:EUDA
Intrinsic Alpha fair value
Locked
Current Price
$17.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.